Waldencast (NASDAQ:WALDW) Trading 4.8% Higher

Shares of Waldencast plc (NASDAQ:WALDW) shot up 4.8% during trading on Wednesday . The stock traded as high as $0.49 and last traded at $0.49. 895 shares traded hands during trading, a decline of 87% from the average session volume of 6,826 shares. The stock had previously closed at $0.47.

Waldencast Stock Performance

The firm’s 50-day moving average is $0.59 and its 200 day moving average is $0.68.

Hedge Funds Weigh In On Waldencast

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Clear Street LLC increased its position in shares of Waldencast by 21.0% in the fourth quarter. Clear Street LLC now owns 148,207 shares of the company’s stock worth $144,000 after acquiring an additional 25,757 shares in the last quarter. Highbridge Capital Management LLC increased its position in shares of Waldencast by 4.4% in the fourth quarter. Highbridge Capital Management LLC now owns 2,419,141 shares of the company’s stock worth $2,347,000 after acquiring an additional 101,592 shares in the last quarter. Cowen AND Company LLC increased its position in shares of Waldencast by 170.0% in the fourth quarter. Cowen AND Company LLC now owns 165,000 shares of the company’s stock worth $160,000 after acquiring an additional 103,900 shares in the last quarter. Wolverine Asset Management LLC increased its position in shares of Waldencast by 224.8% in the fourth quarter. Wolverine Asset Management LLC now owns 31,946 shares of the company’s stock worth $31,000 after acquiring an additional 22,109 shares in the last quarter. Finally, Walleye Capital LLC increased its position in shares of Waldencast by 28.0% in the third quarter. Walleye Capital LLC now owns 576,962 shares of the company’s stock worth $518,000 after acquiring an additional 126,257 shares in the last quarter.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.